[1]KIM M,KIM BH.Current guidelines for management of medullary thyroid carcinoma[J].Endocrinol Metab (Seoul),2021,36(3):514-524.
[2]陈佳铭,房居高,钟琦,等.局部晚期T4a甲状腺乳头状癌R0切除后复发危险因素及生存分析[J].中华耳鼻咽喉头颈外科杂志,2022,57(9):1044-1051.
CHEN JM,FANG JG,ZHONG Q,et al.Risk factors for recurrence and survival analysis in locally advanced T4a papillary thyroid carcinoma after R0 resection[J].Chin J Otorhinolaryngol Head Neck Surg,2022,57(9):1044-1051.
[3]ULSHFER CJ,PFAFENROT C,BINDEREIF A,et al.Methods to study circRNA-protein interactions [J].Methods,2021,196:36-46.
[4]YUAN G,DING W,SUN B,et al.Upregulated circRNA_102231 promotes gastric cancer progression and its clinical significance [J].Bioengineered,2021,12(1):4936-4945.
[5]WU M,KONG C,CAI M,et al.Hsa_circRNA_002144 promotes growth and metastasis of colorectal cancer through regulating miR-615-5p/LARP1/mTOR pathway [J].Carcinogenesis,2022,42(4):601-610.
[6]ZHANG W,LIU H,JIANG J,et al.CircRNA circFOXK2 facilitates oncogenesis in breast cancer via IGF2BP3/miR-370 axis[J].Aging (Albany NY),2021,13(14):18978-18992.
[7]DONG ZR,KE AW,LI T,et al.CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity [J].Mol Cancer,2021,20(1):75.
[8]WEI Y,YANG X,GAO L,et al.Identification of potential immune-related circRNA-miRNA-mRNA regulatory network in cutaneous squamous cell carcinoma [J].Am J Cancer Res,2021,11(10):4826-4843.
[9]HE Y,ZHOU H,WANG W,et al.Construction of a circRNA-miRNA-mRNA regulatory network reveals potential mechanism and treatment options for osteosarcoma [J].Front Genet,2021,12:632359.
[10]WANG X,HE J,WANG H,et al.Fluid shear stress regulates osteoblast proliferation and apoptosis via the lncRNA TUG1/miR-34a/FGFR1 axis [J].J Cell Mol Med,2021,25(18):8734-8747.
[11]LYU C,SUN W,HUANG J,et al.Expression profiles of circular RNAs in human papillary thyroid carcinoma based on RNA deep sequencing [J].Onco Targets Ther,2021,14:3821-3832.
[12]DING H,WANG X,LIU H,et al.Higher circular RNA_0015278 correlates with absence of extrathyroidal invasion,lower pathological tumor stages,and prolonged disease-free survival in papillary thyroid carcinoma patients [J].J Clin Lab Anal,2021,35(7):e23819.
[13]DU G,MA R,LI H,et al.Increased expression of hsa_circ_0002111 and its clinical significance in papillary thyroid cancer [J].Front Oncol,2021,11:644011.
[14]LONG M,CHEN J,ZHU Y,et al.Comprehensive circular RNA profiling reveals the regulatory role of circRNA_0007694 in papillary thyroid carcinoma[J].Am J Transl Res,2020,12(4):1362-1378.
[15]LIU J,XUE N,GUO Y,et al.CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217/Wnt3 pathway[J].Aging (Albany NY),2019,11(24):12412-12427.
[16]HOU J,SHAN H,ZHANG Y,et al.mA RNA methylation regulators have prognostic value in papillary thyroid carcinoma [J].Am J Otolaryngol,2020,41(4):102547.
[17]HE J,ZHOU M,YIN J,et al.METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8-mediated neutrophil infiltration [J].Mol Ther,2021,29(5):1821-1837.
[18]LI YS,XIAO J,BAI J,et al.Molecular characterization and clinical relevance of m6A regulators across 33 cancer types [J].Mol Cancer,2019,18(1):137.
[19]CHI F,CAO Y,CHEN Y.Analysis and validation of circRNA-miRNA network in regulating m(6)A RNA methylation modulators reveals CircMAP2K4/miR-139-5p/YTHDF1 axis involving the proliferation of hepatocellular carcinoma[J].Front Oncol,2021,11:560506.
[20]FANG HN,CHEN ZY,CHEN XY,et al.METTL14-mediated m6A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis [J].Mol Cancer,2022,21(1):51.
[21]LYU W,TAN Y,XIONG M,et al.Analysis and validation of m6A regulatory network:a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression [J].J Transl Med,2021,19(1):527.
[22]MA J,KAN Z.Circ_0137287 suppresses cell tumroigenesis and aerobic glycolysis in papillary thyroid carcinoma through miR-183-5p/PPP2R2A axis [J].Cytotechnology,2021,73(3):497-511.
[23]WANG WL,HUANG CM,LUO P,et al.Circular RNA circWDR27 promotes papillary thyroid cancer progression by regulating miR-215-5p/TRIM44 axis[J].Onco Targets Ther,2021,14:3281-3293.
[24]WANG Y,ZONG H,ZHOU H.Circular RNA circ_0062389 modulates papillary thyroid carcinoma progression via the miR-1179/high mobility group box 1 axis [J].Bioengineered,2021,12(1):1484-1494.
[25]JIN X,WANG Z,PANG W,et al.Upregulated hsa_circ_0004458 contributes to progression of papillary thyroid carcinoma by inhibition of miR-885-5p and activation of RAC1[J].Med Sci Monit,2018,24:5488-5500.
[26]LI Q,CHEN W,LUO R,et al.Upregulation of OIP5-AS1 predicts poor prognosis and contributes to thyroid cancer cell proliferation and migration [J].Mol Ther Nucleic Acids,2020,20:279-291.
[27]PITT JM,VTIZOU M,DAILLRE R,et al.Resistance mechanisms to immune-checkpoint blockade in cancer:Tumor-intrinsic and -extrinsic factors[J].Immunity,2016,44(6):1255-1269.
[28]CUI L,TIAN X,YAN L,et al.Expression and function of Siglec-15 in RLPS and its correlation with PD-L1:Bioinformatics analysis and clinicopathological evidence[J].Int J Med Sci,2022,19(13):1977-1988.
[29]ZHANG G,JIAO Q,SHEN C,et al.Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer [J].Cancer Sci,2021,112(3):997-1010.
[30]XIANG Z,ZHOU Z,SONG S,et al.Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways[J].Oncogene,2021,40(31):5002-5012.
[31]ANDERSON KG,ODA SK,BATES BM,et al.Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy[J].J Immunother Cancer,2022,10(3):e003959.
[32]胡晓君,雷磊,胡艳,等.B7-H4及Fas、FasL与宫颈癌免疫逃逸机制的关系[J].现代肿瘤医学,2020,28(21):3765-3770.
HU XJ,LEI L,HU Y,et al.Relationship between B7-H4,Fas,FasL and immune escape mechanism of cervical cancer[J].Modern Oncology,2020,28(21):3765-3770.